VCA Stocks

AQUAPHARM Bio-Discovery, a leading Scottish marine biotechnology company, said yesterday it has completed a financing package worth pounds-1.5m and plans to move into the new European Centre for Marine Biotechnology Aquapharm collects samples of bacteria and fungi from the marine environment to build a microbial library and a natural products library. The library could contain previously unknown compounds that may provide cures for diseases or answers to manufacturing problems in the drug industry. Using this library, Aquapharm looks for new antibiotics to fight drugresistant organisms like MRSA, which is found in hospitals.